Antiviral therapy using sofosbuvir combined with ribavirin after transcatheter arterial chemoembolization for hepatitis C virus-related hepatocellular carcinoma with tumor thrombus in the right atrium: a case report

Antiviral therapy using sofosbuvir combined with ribavirin after transcatheter arterial chemoembolization for hepatitis C virus-related hepatocellular carcinoma with tumor thrombus in the right atrium: a case report

Bibliographic Details
Main Author:	LI Cuicui
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2018-01-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	liver neoplasms; hepatitis C; chemoembolization therapeutic; antiviral agents; case reports
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=8696

Similar Items

Prognostic factors for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma complicated by portal vein tumor thrombus
by: ZHANG Cheng, et al.
Published: (2016-01-01)

Prognostic factors for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
by: MA Shijie, et al.
Published: (2016-01-01)

Biliary complications after transcatheter arterial chemoembolization for hepatocellular carcinoma
by: Yoon Suk Lee, et al.
Published: (2020-01-01)

Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:
by: GAO Sheng
Published: (2014-09-01)

Rupture of hepatocellular carcinoma after transcatheter arterial chemoembolization: A case report
by: Hye Hyeon Moon, et al.
Published: (2021-01-01)

Prognostic factors in patients with hepatitis B-related primary liver cancer treated with transcatheter arterial chemoembolization
by: YIN Hao
Published: (2014-01-01)

Successful treatment of large advanced stage hepatocellular carcinoma with hepatic and portal vein tumor thrombus by transcatheter arterial chemoembolization combined with microwave ablation: a case report
by: YUAN Zhuhui, et al.
Published: (2018-03-01)

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
by: Zhang YF, et al.
Published: (2016-07-01)

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
by: Sun Hong Yoo, et al.
Published: (2016-12-01)

Clinical effect of transcatheter arterial chemoembolization combined with argon-helium cryoablation in patients with advanced unresectable primary hepatocellular carcinoma
by: NI Mingli
Published: (2015-01-01)

Analysis of factors affecting the prognosis of transcatheter arterial chemoembolization for hepatitis B-related hepatocellular carcinoma
by: Jiangping Cun, et al.
Published: (2021-05-01)

Necrosis of Hepatocellular Carcinoma Caused by Iatrogenic Hepatic Artery Dissection during Transcatheter Arterial Chemoembolization
by: Gu-Seong Jeong, et al.
Published: (2019-05-01)

Efficacy of nutritional intervention in patients with primary hepatocellular carcinoma treated by transcatheter arterial chemoembolization
by: HU Caixia
Published: (2015-04-01)

A Case Series of Liver Abscess Formation after Transcatheter Arterial Chemoembolization for Hepatic Tumors
by: Wei Sun, et al.
Published: (2017-01-01)

A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma
by: Song-I Bae, et al.
Published: (2012-09-01)

Clinical efficacy of Zisheng pills in treatment of adverse reactions in patients with primary hepatocellular carcinoma after transcatheter arterial chemoembolization
by: LIU Xiaping
Published: (2015-01-01)

Palliative Transcatheter Arterial Chemoembolization for Relieving Metastatic Bone Pain due to Hepatocellular Carcinoma: A Case Report
by: Hye Ji Ryu, et al.
Published: (2018-10-01)

Clinical effect of transcatheter arterial chemoembolization combined with tegafur, gimeracil, and oteracil potassium in treatment of advanced hepatocellular carcinoma
by: ZHANG Cheng
Published: (2014-01-01)

CASE OF TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA OF THE LIVER THROUGH THE HEPATIC ARTERY CHEMOEMBOLIZATION M
by: A. I. Gritsaenko, et al.
Published: (2017-01-01)

Survival analysis of intrahepatic arterial infusion of Endostar combined with transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma
by: LIU Qi
Published: (2015-02-01)

Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma
by: Chia-I. Lin, et al.
Published: (2011-12-01)

Role of triphasic computed tomography in prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma patients
by: Ahmed A.E Hassan Desoky, et al.
Published: (2019-01-01)

Curative effect and prognostic impact of radical resection assisted by transcatheter arterial chemoembolization in treatment of intrahepatic cholangiocarcinoma
by: TANG Xiao
Published: (2015-02-01)

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
by: Xiu-Ping Zhang, et al.
Published: (2017-12-01)

Clinical Analysis of Pulmonary Lipiodol Embolism in Patients with Hepatic Carcinoma after Transcatheter Arterial Chemoembolization
by: Wen-jin JIANG, et al.
Published: (2015-03-01)

Current status of transcatheter arterial chemoembolization combined with radiofrequency ablation in treatment of primary liver cancer
by: LYU Tianshi, et al.
Published: (2016-01-01)

Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan
by: Chen-Hua Liu, et al.
Published: (2020-12-01)

Hepatic arterial changes following iodized oil chemoembolization of hepatocellular carcinoma: Incidence and technical consequence
by: Ron C. Gaba, et al.
Published: (2011-09-01)

Research advances in transarterial chemoembolization combined with sorafenib in treatment of advanced hepatocellular carcinoma
by: WU Lei, et al.
Published: (2018-04-01)

Transcatheter hepatic arterial chemoembolization in cirrhotic patients with hepatocellular carcinoma before liver transplantation: the prognostic value of alpha-fetoprotein concentrations
by: D. A. Granov, et al.
Published: (2021-01-01)

A Rare Complication Following Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Wei-Chen Lin, et al.
Published: (2015-12-01)

Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles
by: Toshiyuki Irie, et al.
Published: (2020-01-01)

Efficacy of transcatheter arterial chemoembolization alone or combined with microwave ablation in treatment of primary large liver cancer: a comparative analysis
by: CHANG Peng
Published: (2015-06-01)

Intraductal migration of necrotic hepatocellular carcinoma: A possible cause of obstructive cholangitis after chemoembolization
by: Hyo Jung Park, et al.
Published: (2018-04-01)

Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients
by: Kang Hyun Park, et al.
Published: (2020-03-01)

Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis
by: Shuanggang Chen, et al.
Published: (2020-01-01)

Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
by: Zhiying Shao, et al.
Published: (2021-10-01)

Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
by: Inderpreet Grover, et al.
Published: (2014-10-01)

Clinical effect of systemic chemotherapy combined with transcatheter arterial chemoembolization in treatment of breast cancer with liver metastases
by: LI Liye
Published: (2016-01-01)

Comparative Analysis of Image Quality and Adverse Events between Iopamidol 250 and Ioversol 320 in Hepatic Angiography for Transcatheter Arterial Chemoembolization
by: Min Jae Gu, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_vrabsn4faikg629tesqbroehv4